Introduction {#sec1-1}
============

The propagation of the species is a basic aim of nature. In the multiplication of the human race, "woman has a pivotal role to play." Menopause is generally defined as cessation of periods for 12 months or a period equivalent to 3 previous cycles or as time of cessation of ovarian function resulting in permanent amenorrhea.\[[@ref1]\] The menopause is thus a gradual and natural transitional phase of adjustment between the active and inactive ovarian function and occupies several years of a women\'s life and involves biological and psychological changes adjustments. This period is usually associated with unavoidable manifestation of aging process in women.\[[@ref2]\] Most women experience near complete loss of production of estrogen by their mid-fifties.\[[@ref3]\] During reproductive years, women are protected by female hormones, i.e. estrogen and progesterone. With menopause, women enter an estrogen deficient phase in their lives, which accelerates the ageing process resulting into greater vulnerability to psychosomatic problems. Hot flushes, sweating, changes in mood and libido are some of the important outcomes affecting the quality of life (QoL) during climacterium in women. QoL covers physical, functional, emotional, social, and cognitive variables up to 85% of menopausal women.\[[@ref4]\]

Though, *Rajonivritti* as a diseased condition is not described separately in the classical Ayurveda texts, *Rajonivritti Kala* is mentioned by almost all *Acharyas* without any controversy. According to *Sushruta*\[[@ref5]\] and various other references too\[[@ref6]--[@ref8]\]50 years is mentioned as the age of *Rajonivritti*, when the body is fully in grip of senility.\[[@ref9]\]

Currently, the number of menopausal women is about 43 million and projected figures in 2026 have estimated to be 103 million.\[[@ref10]\] So, menopausal health demands even higher priority in Indian scenario.\[[@ref11]\] In modern science, hormone replacement therapy is one and only alternative for these health hazards, but it has a wider range of secondary health complications like vaginal bleeding, breast cancer, endometrial cancer, gallbladder diseases, etc.\[[@ref12]--[@ref15]\] On the other hand, this therapy is not much effective in the psychological manifestations of this stage. Allopath manages them by the long-term use of sedative, hypnotics, and anxiolytic drugs, which may lead to various side effects like drowsiness, impaired motor function, loss of memory, allergic reactions, non-social behaviors, drug dependence, etc.

Therefore, considering it as a challengeable melody, this project has been undertaken in order to find out a safe and effective medicament in Ayurveda without creating any adverse effect and for the management of menopausal syndrome.

Aims and Objectives {#sec1-2}
===================

The present study was aimed to evaluate efficacy of *Ashokarishta* (ASK), *Ashwagandha Churna* (ASW) and *Praval Pishti* (PP) on menopausal syndrome.

Materials and Methods {#sec1-3}
=====================

Distribution of patients {#sec2-1}
------------------------

Fifty-two patients were randomly selected from O.P.D. of Stree Roga and Prasooti Tantra Department \[[Table 1](#T1){ref-type="table"}\].

###### 

Data of patients
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Inclusion criteria {#sec2-2}
------------------

Females of age between 40 and 55 yearsAmenorrhea for ≥12 monthsKupperman menopausal index score ≥15Follicle Stimulating Hormone (FSH) ≥20 IU/LThickness of endometrium ≤5 mmWilling and able to participate for 16 weeks.

Exclusion criteria {#sec2-3}
------------------

Patients with evidence of malignancySurgical menopauseEstablished cases of mental illness, hyper tension, diabetes mellitus, rheumatoid arthritis, coronary artery disease, hepatic disorders, chronic obstructive pulmonary disease, etc.

Drugs {#sec2-4}
-----

All the drugs, i.e. ASK,\[[@ref16]\] ASW,\[[@ref17]\] and PP were prepared in the Arya Vaidhya Shala, Kottakkal, Kerala, India according to the Ayurvedic Formulary of India.

Investigations {#sec2-5}
--------------

All selected patients were subjected to routine investigations, which included the following:

Blood: Hemoglobin (Hb), Total Count (TC), Differentiate Count (DC), Erythrocyte Sedimentation Rate (ESR), Packed Cell Volume (PCV), etc.Urine: Routine and microscopic examinationBiochemical examination: Fasting blood glucose, total serum proteins, lipid profile, alkaline phosphatase, liver function tests, renal function tests, Serum calcium, HbA1C, etc.Hormonal assessment: FSH, LH (Luteinizing Hormone) and S. T~3~, T~4~, TSH (Thyroid Stimulating Hormone).Ultra Sonography - TVS (Trance Vaginal Sonography/Abdomen.), ECG and pap smear

Study design {#sec2-6}
------------

Present study was designed as per Ayurveda clinical trial protocol. It was directed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi as randomized open clinical trial to evaluate the efficacy of trail drugs on menopausal syndrome.

Grouping: Open trial {#sec2-7}
--------------------

In the present study, all the selected patients were given ASK (25 ml twice daily with equal quantity of water, after food, orally), ASW (3 g twice daily with milk, half an hour before food, orally) and PP (1 capsule of 250 mg twice daily with milk, half an hour before food, orally) for 3 months.

Follow-up study {#sec2-8}
---------------

All patients were followed up for 1 month.

Criteria for assessment {#sec2-9}
-----------------------

Detailed history was taken thorough various physical examinations with the data being recorded in a special proforma that was specifically designed by CCRAS for this study.The result was assessed on the basis of menopause rating scale (MRS)\[[@ref18]\] and menopause specific quality of life (MENQOL).\[[@ref19]\] The improvement in the patients was assessed mainly on the basis of relief in the signs and symptoms of the disease.

Criteria for overall assessment of therapy {#sec2-10}
------------------------------------------

The obtained results were measured according to the grades given below:

Completely cured: 100% reliefMarked improvement: \>75%-\<100% reliefModerate improvement: \>50%-75% reliefMild improvement: \>25%-50% reliefUnchanged: Up to 25% relief

Statistical analysis {#sec2-11}
--------------------

The values were expressed as percentage of relief and mean, SEM; MRS and MENQOL data were analyzed by Wilcoxon matched paired test, while other parameters were analyzed by students paired '*t*' test.

Observations and Results {#sec1-4}
========================

In the present study, maximum 61.53% of patients were from the age group of 50-55 years; 98.08% were married; 96.15% of patients were housewives; 73.08% of patients had disturbed sleep; 76.92% of patients had irregular bowel habit followed by 61.54% had constipation, while 82.69% of patients had frequent urination; 32.69% of the patients had menopause for 2-4 years; 92.31% of patients were having normal BMI (Body Mass Index); 73.08% of patients were not using any contraceptive; 86.54% patients were vegetarian; *Nidana Sevana*, i.e. *Vishamashana* and *Ratrijagarana* were found in maximum patients, i.e. 88.46% and 90.38% respectively; 86.54% of patients were suffering from *Chinta*; 57.69% of patients had *Vatapitta Prakriti*; *Mandagni* was found in 51.92% of the patients. Looking to the sign and symptoms, maximum, i.e. 100% patients were having *Artavavaha and Raktavaha Srotodushti*; In K.I., melancholia was found in 94.23% of patients; In MRS, joint and muscular discomfort was found in 88.46% of patients; 55.77% of patients were having past irregular menstrual history; 57.69% of patients were having moderate quantity of menses, while 59.62% of patients had painless menses.

Effect of Therapy {#sec1-5}
=================

Effect on menopause rating scale {#sec2-12}
--------------------------------

The effect of therapy on MRS has shown that statistically highly significant (*P* \< 0.01) decrease was found in hot flushes by 40.56% relief, in heart discomfort by 84%, in sleep problems by 53.78%, in depressive mood by 41.41%, in irritability by 44.88%, in anxiety by 42.62%, in physical and mental exhaustion by 39.29%, in sexual problems by 18.18%, in bladder problems by 42.42%, in dryness of the vagina by 42.22% and in joint and muscular discomfort by 45.89% relief \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of therapy on menopause rating scale
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Effect on menopause specific quality of life {#sec2-13}
--------------------------------------------

The MENQOL comprises of four sub scales. These are vasomotor, psychosocial, physical and sexual. The effect of therapy on MENQOL has shown that statistically highly significant (*P* \< 0.01) decrease was observed on all above four sub scales. On vasomotor, psychosocial, physical and sexual sub scales, 22.95%, 12.59%, 19.91%, and 2.70% improvement was observed respectively \[[Figure 1](#F1){ref-type="fig"}\].

![Effect on menopause specific quality of life](Ayu-33-511-g003){#F1}

Effect on hematological/biochemical values {#sec2-14}
------------------------------------------

S. calcium was increased by 2.62% upto statistically significant level (*P* \< 0.01). No other significant change in the hematological and biochemical values after treatment was observed in any patient.

Total effect of therapy {#sec2-15}
-----------------------

On the basis of criteria of assessment allotted, the total effect of therapy has been carried out, which has shown that nine patients were moderately improved (17.65%) and 40 patients (78.43%) were mildly improved, while none of the patients were completely improved \[[Figure 2](#F2){ref-type="fig"}\].

![Total effect of therapy](Ayu-33-511-g004){#F2}

Discussion {#sec1-6}
==========

The slogan "Healthy Women, Healthy World" embodies the fact that as custodians of family health, women play a critical role in maintaining the health and well-being of their communities.

*Rajonivritti* is a representative syndrome of *Praudhavastha*, which lies in a *Sandhikala* (a mid-period between *Yuvavastha* and *Vriddhavastha*). During this period there is a peak level of *Pitta*, during *Jarakala*, *Vata* remains in aggravated condition along with vitiated *Pitta* creates hot flushes, excessive sweating, sleep disturbance, irritability, dryness of the vagina, etc., which are similar to *Vataja-Pittaja* symptoms. This is nothing but a *Rajonivritti Avastha Janya Lakshana* or menopausal syndrome. The [Table 3](#T3){ref-type="table"} clarifies this interrelationship.

###### 

Interrelationship between *Vata* and *Rajonivritti*
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Probable mode of action of *Ashokarishta* {#sec2-16}
-----------------------------------------

The drug ASK is having mainly *Madhura, Tikta, Kashaya, Katu Rasa, Sheeta Virya, Madhura Vipaka, Laghu Guna*, and *Tridoshashamaka* properties.\[[@ref16]\] The ingredients are also having *Rasayana, Vayahsthapana, Balya, Medhya, Manasdoshahara, Vedanasthapana*, etc., properties.

As in *Rajonivritti*, as the *Vata Dosha* is dominant, majority of symptoms occur due to *Vatavriddhi*. ASK by its *Snigdha Guna* acts against *Ruksha Guna* of *Vata Dosha* and pacifies it. So, the majority of symptoms of *Rajonivritti* may subside. Moreover, *Agnimandhya* is also, being the common manifestation of *Rajonivritti*. The drug *ASK* by its *Deepana-Pachana* action, acts on *Jatharagni* and relieves the symptom of GIT (Gastro Intestinal Tract) effectively like dyspepsia, decreased appetite, flatulence, constipation, etc.

So, the drug ASK, when administered to the patients through oral route, the probable mode of action is as follows: *Ashoka, Shunthi, Haritaki, Vasa*, and *Chandana* are *Hridya* and *Balya* and act as *Rasayana Karma* may cause *Dhatu Pushti*, which results in *Samprapti Vighatana* and ultimately leads to *Lakshanopshamana*.

*Haritaki, Amalaki*, and *Utpala* directly act as *Rasayana Karma* and further course of action same as discussed above.

*Musta, Ajaji, Sunthi* and *Haritaki* do *Dipana* and *Pachana Karma*, which can lead to *Agni Pradipti* and do *Dhatu Pushti* by doing *Prasasta Dhatu Nirmana*, which results in *Samprapti Vighatana* and ultimately lead to *Lakshanopshamana*.

Finally, *Utpala*, *Haritaki* and *Bibhitaki* are *Medhya* and act as *Manasa* and *Indriya Tarpaka*, which decreases *Chinta*, *Shoka* and sleep disturbances and ultimately lead to *Lakshanopshamana* \[[Chart 1](#F3){ref-type="fig"}\].

![Action of the *Ashokarishta* on disease mechanism](Ayu-33-511-g006){#F3}

Probable mode of action of *Ashwagandha Churna* and *Praval Pishti* {#sec2-17}
-------------------------------------------------------------------

Due to *Balya* and *Vaya-Sthapana* properties of *Ashwagandha* (*Withania somnifera* Dunal.), it directly acts as *Rasayana* and causes *Dhatu Pushti*, which results in *Samprapti Vighatana* and ultimately leads to *Lakshanopashamana*. In case of *Manasa Tarpana*, it supports sound sleep and anti-stress effect due to alcohol, alkaloids and glycosides, which results in *Samprapti Vighatana* and ultimately leads to *Lakshanopashamana*, while in case of *Vajikarana*, it nourishes the reproductive system by improving the sexual dysfunction and further course of action same as discussed above.

Along with this, *Ashwagandha* improves the degenerative changes by effect on chondroplasts in cartilage as well as it creates hemopoetic effect by cyclophosphamide and reduces leukopenia \[[Chart 2](#F4){ref-type="fig"}\].

![Action of the *Ashwagandha Churna* on disease mechanism](Ayu-33-511-g007){#F4}

*Ashwagandha* can affect elements of the central nervous system and the immune system; it might be useful in reducing hot flushes.\[[@ref20]\]

Effect on the inflammatory response {#sec2-18}
-----------------------------------

Prostaglandins cause inflammation and are implicated in the generation of hot flashes. Enzymes such as cyclooxygenase-2 (COX-2), synthesize prostaglandins from cellular lipids. Vanisree Mulabagal and co-workers at Michigan State University showed that *Ashwagandha* inhibited the enzyme activity of COX-2 in laboratory tests.\[[@ref20]\]

Effect on the immune system {#sec2-19}
---------------------------

IL-8 (Interleukin-8) is a potent vasodilator released by macrophages under stressful conditions. According to study conducted at the University of Tokushima, IL-8 was significantly increased in 179 women with hot flashes and it suggests that macrophages sense the decline in estrogen and respond by secreting IL-8. Working with cultured cells, researchers at the University of Buffalo found that *Ashwagandha* decreased the genetic expression of IL-8.\[[@ref20]\]

A withanolide-free aqueous fraction isolated from the roots of *Withania somnifera* exhibited anti-stress activity\[[@ref21]\] in a dose-dependent manner in mice.\[[@ref22]\]

*Praval* is used to treat disorders like *Pitta* aggravation and calcium deficiency because it has got properties like cooling and soothing effect. *Praval* is used with herbal phytoestrogen for better and early result.\[[@ref23]\]

Conclusion {#sec1-7}
==========

The study shows that formulation of these three drugs: ASK, ASW, and PP is better in somatic complaints including GIT disturbances as well as white discharge and hot flushes, etc., It is better in various psychological disturbances mainly include headache, irritability, depression, mood swings, sleep disturbances, etc., So, it can be concluded that in women with mild to moderate symptoms of menopausal syndrome, a combined treatment (ASK + ASW + PP) gives better result in both somatic as well as psychological complaints. No any adverse effect was noted during the study. Therefore it could be a safe alternative to the modern drugs. It is found to be an effective therapy in psychological and somatic problems related with menopausal syndrome.
